|
Category: natural substances and extractives
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Boiling Point: | 467.10 °C. @ 760.00 mm Hg (est)
|
| Flash Point: | 473.00 °F. TCC ( 245.20 °C. ) (est)
|
| logP (o/w): | 2.050 (est) |
| Soluble in: |
| | water, 2022 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
| BOC Sciences |
| For experimental / research use only. |
| Catalpalactone
Odor: characteristic Use: Catalpalactone isolated from the wood of Catalpa ovata. It inhibited dopamine biosynthesis by reducing TH and AADC activities and enhanced L-DOPA-induced cytotoxiciy in PC12 cells. |
| Coompo |
| For experimental / research use only. |
| Catalpalactone from Plants ≥96%
Odor: characteristic Use: The effects of catalpalactone on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells were investigated. Catalpalactone at 5-30然 decreased intracellular dopamine content with the IC(50) value of 22.1然. Catalpalactone at 5-20然, but not 30然, did not alter cell viability. Catalpalactone at 20然 inhibited tyrosine hydroxylase (TH) and aromatic-l-amino acid decarboxylase (AADC) activities. Catalpalactone also decreased cyclic AMP levels and inhibited TH phosphorylation. In addition, catalpalactone at 20然 reduced the increases in dopamine levels induced by L-DOPA (20-50然). Catalpalactone (5-30然) associated with L-DOPA (50-100然) enhanced L-DOPA-induced cytotoxicity at 48h, which was prevented by N-acetyl-l-cysteine. These results suggest that catalpalactone inhibited dopamine biosynthesis by reducing TH and AADC activities and enhanced L-DOPA-induced cytotoxiciy in PC12 cells. |
Safety Information:
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
|
Not determined
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | natural substances and extractives |
| Recommendation for catalpalactone usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for catalpalactone flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
| | 3-(2,2-dimethyl-6-oxo-3H-pyran-5-yl)-3H-2-benzofuran-1-one |
| NIST Chemistry WebBook: | Search Inchi |
| Pubchem (cid): | 3014018 |
| Pubchem (sid): | 135205113 |
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| 1(3H)-iso | benzofuranone, 3-(5,6-dihydro-6,6-dimethyl-2-oxo-2H-pyran-3-yl)- | | 3-(5,6- | dihydro-6,6-dimethyl-2-oxo-2H-pyran-3-yl)-1(3H)-isobenzofuranone | | 3-(6,6- | dimethyl-2-oxo-5,6-dihydro-2H-pyran-3-yl)-2-benzofuran-1(3H)-one | | 3-(2,2- | dimethyl-6-oxo-3H-pyran-5-yl)-3H-2-benzofuran-1-onee |
Articles:
|